OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
Özlem Altay, Muhammad Arif, Xiangyu Li, et al.
Advanced Science (2021) Vol. 8, Iss. 17
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Pleiotropic effects of mitochondria in aging
Tanes Lima, Terytty Yang Li, Adrienne Mottis, et al.
Nature Aging (2022) Vol. 2, Iss. 3, pp. 199-213
Open Access | Times Cited: 151

Advances and Utility of the Human Plasma Proteome
Eric W. Deutsch, Gilbert S. Omenn, Zhi Sun, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 12, pp. 5241-5263
Open Access | Times Cited: 138

A Global Picture: Therapeutic Perspectives for COVID-19
Vivek P. Chavda, Carron Kapadia, Shailvi Soni, et al.
Immunotherapy (2022) Vol. 14, Iss. 5, pp. 351-371
Open Access | Times Cited: 71

Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
Burak Yuluğ, Özlem Altay, Xiangyu Li, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 44

Therapeutic application of natural products: NAD+ metabolism as potential target
Guo Chen, Qingxia Huang, Yisa Wang, et al.
Phytomedicine (2023) Vol. 114, pp. 154768-154768
Closed Access | Times Cited: 44

What is really known about the effects of nicotinamide riboside supplementation in humans
Mads V. Damgaard, Jonas T. Treebak
Science Advances (2023) Vol. 9, Iss. 29
Open Access | Times Cited: 41

The CD38 glycohydrolase and the NAD sink: implications for pathological conditions
Julianna D. Zeidler, Kelly A. Hogan, Guillermo Agorrody, et al.
AJP Cell Physiology (2022) Vol. 322, Iss. 3, pp. C521-C545
Open Access | Times Cited: 46

NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
Gabriela Fabiana Soares Alegre, Gláucia María Pastore
Current Nutrition Reports (2023) Vol. 12, Iss. 3, pp. 445-464
Open Access | Times Cited: 32

Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19
Anar Isman, Andy Nyquist, Bailey Strecker, et al.
Brain Behavior & Immunity - Health (2024) Vol. 36, pp. 100733-100733
Open Access | Times Cited: 12

Genome-scale models in human metabologenomics
Adil Mardinoğlu, Bernhard Ø. Palsson
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 9

Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19
T. Matsuyama, Steven K. Yoshinaga, Kimitaka Shibue, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 12, pp. 3199-3213
Open Access | Times Cited: 47

MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults
Karol M. Pencina, Siva Lavu, Marcelo Rodrigues dos Santos, et al.
The Journals of Gerontology Series A (2022) Vol. 78, Iss. 1, pp. 90-96
Closed Access | Times Cited: 36

The role of antigen-presenting cells in the pathogenesis of COVID-19
Rana Farzi, Parisa Shiri Aghbash, Narges Eslami, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153848-153848
Open Access | Times Cited: 28

NAD+ Metabolism and Immune Regulation: New Approaches to Inflammatory Bowel Disease Therapies
Chaoyue Chen, Wei Yan, Meihui Tao, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1230-1230
Open Access | Times Cited: 18

NAD+ metabolism-based immunoregulation and therapeutic potential
Jiankai Fang, Wangwang Chen, Pengbo Hou, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16

Recent advances in nutritional metabolism studies on SARS-CoV-2 infection
Yue Jiang, Xu Li, Xuexing Zheng, et al.
Infectious Medicine (2025) Vol. 4, Iss. 1, pp. 100162-100162
Open Access

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms
Wen Zhong, Özlem Altay, Muhammad Arif, et al.
EBioMedicine (2021) Vol. 74, pp. 103723-103723
Open Access | Times Cited: 36

Viral infection as an NAD+ battlefield
Charles Brenner
Nature Metabolism (2022) Vol. 4, Iss. 1, pp. 2-3
Open Access | Times Cited: 24

Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions
Kaitlin A. Freeberg, CeAnn C Udovich, Christopher R. Martens, et al.
The Journals of Gerontology Series A (2023) Vol. 78, Iss. 12, pp. 2435-2448
Open Access | Times Cited: 14

Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Shalender Bhasin, Douglas R. Seals, Marie E. Migaud, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 6, pp. 1047-1073
Open Access | Times Cited: 14

The acute effect of different NAD+ precursors included in the combined metabolic activators
Xiangyu Li, Hong Yang, Han Jin, et al.
Free Radical Biology and Medicine (2023) Vol. 205, pp. 77-89
Closed Access | Times Cited: 13

Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases
Özlem Altay, Hong Yang, Serkan Yıldırım, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 927-927
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top